PHASE I STUDY OF NON-PEGYLATED LIPOSOMAL DOXORUBICIN IN CHILDREN WITH RECURRENT/REFRACTORY HIGH GRADE GLIOMA

¹Children University Hospital, Paediatric Oncology Department, Vandoeuvre, France;²University Hospital la Timone-AP-HM, Pharmacokinetic and Toxicology Laboratory, Marseille, France;³Gustave Roussy, Paediatric and Adolescent Oncology Department, Villejuif, France;⁴Curie Institute, Paediatric Adolescent and Young Adults Oncology Department, Paris, France;⁵Oscar Lambret, Paediatric Oncology Department, Lille, France;⁶Institut d'Hémato-Oncologie Pédiatrique, Institut d'Hémato-Oncologie Pédiatrique- Lyon, Lyon, France;⁷University Hospital la Timone-AP-HM, Paediatric Oncology Department, Marseille, France